Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.40
-2.62 (-2.11%)
Nov 20, 2026, 4:00 PM EST - Market closed
Protagonist Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 498.3 | 128.39 | 97.25 | 186.73 | 125.74 | 123.67 |
Short-Term Investments | 301.77 | 438.97 | 321.66 | 154.89 | 111.61 | 203.24 |
Cash & Short-Term Investments | 800.06 | 567.36 | 418.91 | 341.62 | 237.36 | 326.9 |
Cash Growth | 38.87% | 35.44% | 22.63% | 43.93% | -27.39% | 6.90% |
Accounts Receivable | 287.79 | 0.12 | 165 | 10 | 0.01 | 1.57 |
Other Receivables | 8.12 | 4.38 | 3.49 | 0.33 | 0.04 | 3.77 |
Receivables | 295.91 | 4.5 | 168.49 | 10.33 | 0.05 | 5.33 |
Prepaid Expenses | 3.96 | 5.71 | 4.24 | 3.63 | 5.67 | 8.5 |
Other Current Assets | 1.12 | - | - | - | - | - |
Total Current Assets | 1,101 | 577.57 | 591.64 | 355.58 | 243.08 | 340.74 |
Property, Plant & Equipment | 9.82 | 11.69 | 12.61 | 2.15 | 4.63 | 6.73 |
Long-Term Investments | 34.56 | 78.64 | 140.25 | - | - | - |
Other Long-Term Assets | 1.12 | 0.29 | 0.23 | 0.23 | 0.23 | 0.23 |
Total Assets | 1,147 | 668.19 | 744.73 | 357.95 | 247.93 | 347.7 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.92 | 5.34 | 1.62 | 0.77 | 3.64 | 1.6 |
Accrued Expenses | 25.98 | 28.08 | 23.62 | 19.26 | 24.54 | 37.31 |
Current Portion of Leases | 2.45 | 2.28 | 0.51 | 1.14 | 2.52 | 2.2 |
Current Income Taxes Payable | 4.22 | - | 2.69 | - | - | - |
Current Unearned Revenue | 16.31 | 9.55 | 18.89 | - | - | 1.6 |
Other Current Liabilities | 0.58 | 0.19 | 0.07 | 0.1 | 0.48 | 1.31 |
Total Current Liabilities | 55.46 | 45.44 | 47.4 | 21.27 | 31.18 | 44.02 |
Long-Term Leases | 6.18 | 8.04 | 10.36 | - | 1.14 | 3.66 |
Long-Term Unearned Revenue | - | - | 11.68 | - | - | - |
Total Liabilities | 61.64 | 53.48 | 69.43 | 21.27 | 32.32 | 47.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | - | - |
Additional Paid-In Capital | 1,176 | 1,085 | 1,016 | 952.49 | 752.72 | 709.68 |
Retained Earnings | -84.02 | -470.67 | -340.52 | -615.71 | -536.76 | -409.36 |
Comprehensive Income & Other | -1.3 | 0.64 | -0.08 | -0.11 | -0.36 | -0.3 |
Total Common Equity | 1,085 | 614.71 | 675.3 | 336.68 | 215.61 | 300.02 |
Shareholders' Equity | 1,085 | 614.71 | 675.3 | 336.68 | 215.61 | 300.02 |
Total Liabilities & Equity | 1,147 | 668.19 | 744.73 | 357.95 | 247.93 | 347.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.63 | 10.32 | 10.87 | 1.14 | 3.66 | 5.86 |
Net Cash (Debt) | 825.99 | 635.68 | 548.3 | 340.48 | 233.7 | 321.04 |
Net Cash Growth | 23.64% | 15.94% | 61.04% | 45.69% | -27.21% | 6.36% |
Net Cash Per Share | 11.89 | 10.00 | 8.43 | 6.00 | 4.77 | 6.93 |
Filing Date Shares Outstanding | 65.27 | 63.81 | 61.38 | 58.27 | 51.28 | 48.41 |
Total Common Shares Outstanding | 65.22 | 62.58 | 61.04 | 57.71 | 49.34 | 47.84 |
Working Capital | 1,046 | 532.13 | 544.24 | 334.3 | 211.9 | 296.72 |
Book Value Per Share | 16.64 | 9.82 | 11.06 | 5.83 | 4.37 | 6.27 |
Tangible Book Value | 1,085 | 614.71 | 675.3 | 336.68 | 215.61 | 300.02 |
Tangible Book Value Per Share | 16.64 | 9.82 | 11.06 | 5.83 | 4.37 | 6.27 |
Machinery | 9.84 | 9.24 | 7.8 | 6.47 | 5.91 | 5.18 |
Leasehold Improvements | 3.01 | 2.94 | 2.42 | 0.96 | 0.91 | 0.88 |